ESMO 2022 Conference Coverage
S

ESMO 2022 Liquid Biopsy for Detection of Molecular Residual Disease and Recurrence in Head and Neck Squamous Cell Carcinoma

By ESMO 2022 Conference Coverage FEATURING Susanne Flach
By ESMO 2022 Conference Coverage FEATURING Susanne Flach
0 views
September 14, 2022
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
09:00
AAD 2024 Insights

AAD 2024 Insights: What's New In Nail Tumors

Feat. J. Dominguez-Cherit
13:58
Dana-Farber Cancer Institute

Lynch Syndrome and Skin: A Dermatologist’s Perspective

Feat. V. Nambudiri
11:53
AAD 2024 Insights

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

Feat. V. Patel
26:24
EADV 2023 Insights

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

Feat. G. Hofbauer
13:21
NYU Langone

Management of High Risk Squamous Cell Carcinoma

Feat. M. L. Stevenson
21:20
Dana-Farber Cancer Institute

Year in Review: Updates in Non-Melanoma Skin Cancers

Feat. K. Khaddour
05:58
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV …

Feat. N. Gross
58:44
Head and Neck Symposium: Skin Malignancies Update

Updates in non-Melanoma Skin Cancer

Feat. S. Daveluy
47:34
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Head & Neck Cancer Updates

Feat. C. Rodriguez
27:29
Total Health

2023 ASCO® Direct Philadelphia: Melanoma Updates

Feat. M. Orloff
15:39
ImmunoTherapy Bridge 2023

Neoadjuvant IO: Non-Melanoma Skin Cancer

Feat. N. Gross
23:44
Todd Schlesinger

PD-1 Inhibitors for Advanced Basal Cell Carcinoma and Squamous Cell …

15:54
ImmunoTherapy Bridge 2023

Non-Melanoma Skin Cancers

Feat. P. A. Ascierto
24:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "To Treat or Not to Treat - Challenging Sc…

Feat. K. Margolin
27:58
Yale Cancer Center

Understanding Skin Cancer: Diagnosis, Biopsy, Risks, and Treatment O…

Feat. J. Clune
02:41
ecancer

ESMO 2023 Insights: "Survival Results for Neoadjuvant Cemiplima…

Feat. N. Gross
18:56
Yale Cancer Center

Immunotherapy and Anti-Angiogenic Therapies in HNSCC

Feat. A. Bhatia
12:13
AACR 2023 Conference Coverage

Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Ant…

Feat. E. Cohen
09:00
Winship Cancer Institute - Emory University

Harnessing IO in the Management of CSCC

Feat. N. Saba